The current drugs used for T2DM treatment include insulin secretagogues, biguanides, insulin sensitizers, alpha glucosidase inhibitors, incretin mimetics, amylin antagonists, and sodium-glucose co-transporter-2 (SGLT2) inhibitors [10]. The gene discussed is INS; the disease is type 2 diabetes mellitus.